Heron Therapeutics Inc (HRTX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Heron Therapeutics Inc   (NASDAQ: HRTX)
 

Heron Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Heron Therapeutics Inc inventory turnover ratio, the Heron Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.53 in the second quarter 2026, yet the ratio remained below the average, as HRTX's market remain challenging.Average inventory processing period, for the Heron Therapeutics Inc in Jun 30 2026 quarter, has decreased to 689 days, compare to 702 days, in the Mar 31 2026 quarter.

Within Healthcare sector 351 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1296 in the first quarter 2026, to 1903.

HRTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Heron Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HRTX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 24.15 % 62.54 % 74.47 % 52.39 % 70.22 %
Y / Y Cost of Sales Growth 28.58 % 25 % 18.18 % 22.22 % -10 %
Inventory Turnover Ratio (TTM) 0.53 0.52 0.56 0.62 0.65
HRTX's Total Ranking # 1903 # 1296 # 1410 # 1188 # 1571
Average inventory processing period 693 697 651 592 565
Seq. Inventory Growth -2.11 % -0.22 % 32.45 % -4.03 % 28.16 %
Seq. Cost of Sales Growth 15.72 % -23.08 % 18.18 % 22.22 % 12.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 110
Healthcare Sector # 352
Overall Market # 1903

Inventory Turnover Ratio Statistics
High Average Low
2.24 0.99 0.01
(Dec 31 2019)   (Dec 31 2016)



HRTX Company Profile >> Back to HRTX Efficiency Comparisons >> Compare HRTX Inventory Turnover Ratio to its Competitors

Financial Statements
Heron Therapeutics Inc 's Inventories $ 91 Millions Visit HRTX's Balance sheet
Heron Therapeutics Inc 's Cost of Revenues TTM $ 46 Millions Visit HRTX's Income Statement
What are HRTX's Sales? Visit HRTX's Sales by Segment

Other Inventory Turnover Ratios
Heron Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HRTX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HRTX's Competitors
Inventory Turnover Ratio for HRTX's Suppliers
Inventory Turnover Ratio for HRTX's Customers

You may also want to know
HRTX's Sales Growth Rates HRTX's Pe Price to earnings ratio HRTX's Receivables Turnover Ratio HRTX's Stock Quote
HRTX's Net Income Growth Rates HRTX's Ps Price to Sales ratio HRTX's Sales per Employee HRTX's Asset Turnover Ratio
HRTX's Net Margin HRTX's Pb Price to Book ratio HRTX's Financial Strength Ratios HRTX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Lensar Inc   1.38 $ 31.126  Millions$ 23  Millions
Arcutis Biotherapeutics Inc   1.35 $ 41.096  Millions$ 30  Millions
Alphatec Holdings Inc   1.32 $ 237.415  Millions$ 179  Millions
Tenet Healthcare Corp  1.32 $ 453.000  Millions$ 344  Millions
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions
Edwards Lifesciences Corporation  1.28 $ 1,443.400  Millions$ 1,129  Millions
Globus Medical Inc   1.27 $ 989.145  Millions$ 779  Millions
Karyopharm Therapeutics Inc   1.27 $ 4.942  Millions$ 4  Millions
Clene Inc   1.25 $ 0.059  Millions$ 0  Millions
Kyntra Bio Inc   1.24 $ 4.444  Millions$ 4  Millions
Pulmonx Corporation  1.24 $ 20.014  Millions$ 16  Millions
Biolife Solutions Inc   1.24 $ 39.035  Millions$ 32  Millions
Stereotaxis Inc   1.23 $ 13.184  Millions$ 11  Millions
60 Degrees Pharmaceuticals Inc   1.20 $ 0.895  Millions$ 1  Millions
Delcath Systems Inc   1.16 $ 12.355  Millions$ 11  Millions
Bridgebio Pharma Inc   1.16 $ 39.655  Millions$ 34  Millions
Neuropace Inc   1.14 $ 19.920  Millions$ 17  Millions
Amarin Corp Plcuk  1.13 $ 108.346  Millions$ 96  Millions
Treace Medical Concepts Inc   1.10 $ 42.186  Millions$ 38  Millions
Corcept Therapeutics Inc  1.10 $ 14.085  Millions$ 13  Millions
Bio Green Med Solution Inc   1.07 $ 1.244  Millions$ 1  Millions
Hyperfine Inc   1.06 $ 6.924  Millions$ 7  Millions
Pacira Biosciences inc   1.04 $ 155.154  Millions$ 149  Millions
Humacyte Inc   1.03 $ 12.611  Millions$ 12  Millions
Vertex Pharmaceuticals Inc  1.03 $ 1,762.800  Millions$ 1,711  Millions
Emergent Biosolutions Inc   1.02 $ 339.900  Millions$ 333  Millions
Renovorx Inc   1.01 $ 0.308  Millions$ 0  Millions
Alkermes Plc   1.01 $ 257.490  Millions$ 256  Millions
Rhythm Pharmaceuticals Inc   0.99 $ 26.389  Millions$ 27  Millions

Date modified: 2026-08-14T05:10:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.